Merck (NYSE: MRK) said that the Data Safety Monitoring Board (DSMB) of the IMPROVE-IT trial has completed its planned review ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE